Placental Molybdenum Accumulation Is Associated with Reduced Birthweight: A Pilot Study of Metal-Specific Placental Profiles in Hypertensive and Normotensive Pregnancies

Technical Summary: Placental Molybdenum Accumulation and Reduced Birthweight

Problem Statement
Environmental exposure to trace metals is a recognized determinant of maternal-fetal health, with well-documented adverse effects from heavy metals such as lead (Pb), cadmium (Cd), and arsenic (As). These elements can cross the maternal-fetal interface, accumulate in placental tissue, and disrupt trophoblastic function, oxidative balance, and angiogenic signaling, potentially leading to hypertensive disorders of pregnancy (HDP) and fetal growth restriction. However, the impact of less frequently studied trace elements, specifically molybdenum (Mo), on fetal growth remains poorly understood. While Mo is an essential trace metal involved in oxidative metabolism and cellular detoxification, the relationship between its placental accumulation and neonatal birthweight has not been clearly established. This pilot study addresses this gap by characterizing placental metal profiles in hypertensive versus normotensive pregnancies and investigating their associations with neonatal birthweight.

Methodology
The study employed a pilot analytical design involving 21 pregnant women who delivered between 37 and 40 weeks of gestation at Çankırı State Hospital. Participants were stratified into two groups: normotensive (n=11) and hypertensive (n=10).

• Sample Collection: Approximately 5 g of placental tissue was excised from the central cotyledon, avoiding calcified or infarcted areas. Samples were washed with ultrapure deionized water, dried at 60°C for 96 hours, and homogenized.
• Elemental Analysis: Concentrations of As, Cd, Pb, and Mo were quantified using Inductively Coupled Plasma–Mass Spectrometry (ICP–MS) following microwave-assisted acid digestion. Quality control included certified reference materials (NIST 1577c), procedural blanks, and triplicate measurements, with recovery rates between 92% and 108%.
• Statistical Analysis: Due to the small sample size and non-normal distribution of metal concentrations, non-parametric tests (Mann–Whitney U, Spearman's rank correlation, Kruskal–Wallis) were utilized. Multivariable linear regression was performed to assess the independent association between placental Mo and birthweight, adjusting for gestational age. Placental Mo concentrations were natural log-transformed to address skewness.

Key Results

1. Hypertensive Status and Metal Accumulation: Placental concentrations of As and Cd were significantly higher in hypertensive pregnancies compared to normotensive ones (As: p=0.024; Cd: p=0.041). No significant differences were found for Mo or Pb between the two groups.
2. Molybdenum and Birthweight: A strong inverse correlation was observed between placental Mo levels and neonatal birthweight (Spearman ρ = -0.789, p < 0.001).
3. Dose-Response Relationship: Birthweight demonstrated a significant decline across Mo tertiles. The median birthweight decreased from 3676 g in the low Mo tertile to 2697 g in the high Mo tertile (p for trend = 0.004).
4. Multivariable Regression: After adjusting for gestational age, log-transformed placental Mo concentrations remained a significant independent predictor of reduced birthweight (B = -1554.10, p < 0.001). The model explained 79% of the variance in birthweight (R² = 0.79).
5. Lead Findings: While univariate analysis showed a negative correlation between Pb and birthweight (ρ = -0.564, p=0.008), this association lost statistical significance after adjusting for gestational age.

Significance and Claims
The authors posit that placental metal accumulation patterns are differentially associated with pregnancy outcomes. The primary contribution of this study is the identification of placental molybdenum accumulation as a strong, independent predictor of reduced neonatal birthweight, a finding that persists even after controlling for gestational age. This suggests that excessive Mo accumulation may disrupt redox homeostasis or essential trace element metabolism (potentially via copper antagonism), thereby impairing fetal growth.

The study also reinforces the link between toxic metals (As and Cd) and hypertensive disorders of pregnancy, consistent with existing literature on oxidative stress and endothelial dysfunction. However, the authors maintain a modest tone, acknowledging the pilot nature of the research. They explicitly state that the study cannot establish causality due to its cross-sectional design and small sample size. The significance of these findings lies in providing preliminary evidence that warrants larger prospective studies to elucidate the mechanistic pathways linking molybdenum exposure to impaired fetal growth and to validate metal-specific placental profiling as a tool for understanding environmental determinants of perinatal health.